ClinicalTrials.gg
CompletedNCT02594085Updated Jan 20, 2016

An Exploratory Study Investigating Adhesive Reaction to Output

An interventional study of Patch 1 and Patch 2 in Ileostomy, sponsored by Coloplast A/S. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-01-20.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective is to investigate the impact that faecal output has on adhesives.

02

Conditions studied

  • Ileostomy
03

In context

Lead sponsor

Coloplast A/S is the lead sponsor of 150 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Have given written informed consent
  2. Be at least 18 years of age and have full legal capacity
  3. Have had an ileostomy for more than 3 months
  4. Have intact skin on the area used in the evaluation
  5. Has an ileostomy with a diameter (≤) 35mm

Exclusion criteria

Exclusion Criteria:

  1. Currently receiving or have within the past 2 month received radio- and/or chemotherapy
  2. Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment
  3. Are pregnant or breastfeeding
  4. Having dermatological problems in the peristomal area
  5. Convex user
  6. Participate in other interventional clinical investigations
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Patch 3/Patch4 + Patch1/patch2 + patch 5/patch 6

    The subjects test 6 adhesive strips; two in each test period. The patches are tested in pairs i.e Patch 1 and patch 2 are a pair; Patch 3 and Patch 4 are a piar and patch 5 and patch 6 are a pair. The test order of the patch pairs is randomised between the three periods. In this arm the the subjects test: Test period 1: Patch 3 and Patch 4 Test period 2: Patch 1 and Patch 2 Test period 3: Patch 5 and Patch 6

    Other: Patch 1 · Other: Patch 2 · Other: Patch 3 · Other: Patch 4 · Other: patch 5 · Other: Patch 6

  • Experimental
    Patch 1/Patch2 + Patch3/patch4 + patch 5/patch 6

    The subjects test 6 adhesive strips; two in each test period. The patches are tested in pairs i.e Patch 1 and patch 2 are a pair; Patch 3 and Patch 4 are a piar and patch 5 and patch 6 are a pair. The test order of the patch pairs is randomised between the three periods. In this arm the the subjects test: Test period 1: Patch 1 and Patch 2 Test period 2: Patch 3 and Patch 4 Test period 3: Patch 5 and Patch 6

    Other: Patch 1 · Other: Patch 2 · Other: Patch 3 · Other: Patch 4 · Other: patch 5 · Other: Patch 6

  • Experimental
    Patch 1/Patch2 + Patch5/patch 6 + patch 3/patch 4

    The subjects test 6 adhesive strips; two in each test period. The patches are tested in pairs i.e Patch 1 and patch 2 are a pair; Patch 3 and Patch 4 are a piar and patch 5 and patch 6 are a pair. The test order of the patch pairs is randomised between the three periods. In this arm the the subjects test: Test period 1: Patch 1 and Patch 2 Test period 2: Patch 3 and Patch 4 Test period 3: Patch 5 and Patch 6

    Other: Patch 1 · Other: Patch 2 · Other: Patch 3 · Other: Patch 4 · Other: patch 5 · Other: Patch 6

  • Experimental
    Patch 3/Patch4 + Patch5/patch6 + patch 3/patch 4

    The subjects test 6 adhesive strips; two in each test period. The patches are tested in pairs i.e Patch 1 and patch 2 are a pair; Patch 3 and Patch 4 are a piar and patch 5 and patch 6 are a pair. The test order of the patch pairs is randomised between the three periods. In this arm the the subjects test: Test period 1: Patch 3 and Patch 4 Test period 2: Patch 5 and Patch 6 Test period 3: Patch 1 and Patch 2

    Other: Patch 1 · Other: Patch 2 · Other: Patch 3 · Other: Patch 4 · Other: patch 5 · Other: Patch 6

  • Experimental
    Patch 5/Patch 6 + Patch 3/patch 4 + patch 1/patch 2

    The subjects test 6 adhesive strips; two in each test period. The patches are tested in pairs i.e Patch 1 and patch 2 are a pair; Patch 3 and Patch 4 are a piar and patch 5 and patch 6 are a pair. The test order of the patch pairs is randomised between the three periods. In this arm the the subjects test: Test period 1: Patch 5 and Patch 6 Test period 2: Patch 3 and Patch 4 Test period 3: Patch 1 and Patch 2

    Other: Patch 1 · Other: Patch 2 · Other: Patch 3 · Other: Patch 4 · Other: patch 5 · Other: Patch 6

  • Experimental
    Patch 5/Patch 6 + Patch1/patch2 + patch 3/patch 4

    The subjects test 6 adhesive strips; two in each test period. The patches are tested in pairs i.e Patch 1 and patch 2 are a pair; Patch 3 and Patch 4 are a piar and patch 5 and patch 6 are a pair. The test order of the patch pairs is randomised between the three periods. In this arm the the subjects test: Test period 1: Patch 1 and Patch 2 Test period 2: Patch 3 and Patch 4 Test period 3: Patch 5 and Patch 6

    Other: Patch 1 · Other: Patch 2 · Other: Patch 3 · Other: Patch 4 · Other: patch 5 · Other: Patch 6

Interventions

  • OtherPatch 1

    Patch 1 describes a test system which contains an adhesive strip and an adhesive patch with a sleeve. The sleeve of Patch 1 contains the subjects own feces. The Patch is placed over the adhesive strip to investigate the impact of output on the adhesive strip

  • OtherPatch 2

    Patch 2 describes a test system which contains an adhesive strip and an adhesive patch with a sleeve. The sleeve Patch 2 contains the subjects own feces and filler. The Patch is placed over the adhesive strip to investigate the impact of output on the adhesive strip

  • OtherPatch 3

    Patch 3 describes a test system which contains an adhesive strip and an adhesive patch with a sleeve. The sleeve of Patch 3 contains simulated output. The Patch is placed over the adhesive strip to invesitgate the impact of output on the adhesive strip

  • OtherPatch 4

    Patch 4 describes a test system which contains an adhesive strip and an adhesive patch with a sleeve. The sleeve of Patch 4 contains simulated output with filler. The Patch is placed over the adhesive strip to investigate the impact of output on the adhesive strip

  • Otherpatch 5

    Patch 5 describes a test system which contains an adhesive strip and an adhesive patch with a sleeve. The sleeve of Patch 5 contains buffer. The Patch is placed over the adhesive strip to investigate the impact of output on the adhesive strip

  • OtherPatch 6

    Patch 6 describes a test system which contains an adhesive strip and an adhesive patch with a sleeve. The sleeve of Patch 6 contains buffer with filler. The Patch is placed over the adhesive strip to investigate the impact of output on the adhesive strip

06

What researchers measure

Primary outcomes

  1. Remaining adherent area of the adhesive

    The remaining adherent area of the adhesive strips is assessed by measuring the difference in total area of output and swelling.

    Time frame: 8 hours

07

Study locations

1 site
  • Coloplast A/S
    Humlebæk, 3050, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02594085
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
Nov 2, 2015
Start date
Oct 2015
Primary completion
Jan 2016
Completion
Jan 2016
Last update
Jan 20, 2016

Study contacts

Birte P Jakobsen, MD
principal investigator · Medical Director

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion